☰ Neurotree

cached image

Peter Davies, PhD

Affiliations:

Pathology and Neuroscience

Albert Einstein College of Medicine, New York, New York, United States

Area:

Alzheimer's, Apoptosis, Amyloid, Phosphorylation

Website:

http://www.einstein.yu.edu/pathology/faculty_Profile.asp?personID=3146

Google:

Bio:

http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=37

Mean distance: 15.3 (cluster 11)

Cross-listing: Alzheimer's Tree

Tree Publications Grants Similar researchers PubMed Report error

Parents

Children

Gregory A. Jicha	grad student	2000	Yeshiva University
Charles L. Weaver	grad student	2001	Yeshiva University
Cathy A. Andorfer	grad student	2003	Yeshiva University
Christopher G. Conrad	grad student	2004	Yeshiva University
Adrianna Z. Herskovits	grad student	2006	Yeshiva University
Marisol Espinoza Pintucci	grad student	2007	Yeshiva University
Pankajavalli Ramakrishnan	grad student	2007	Yeshiva University
Manuela Polydoro	grad student	2010	Yeshiva University
Sarah D. Schlatterer	grad student	2012	Yeshiva University
Stefanie K. Forest	grad student	2014	Yeshiva University
Robert P. Bowser	post-doc		Albert Einstein Medical College BIMC
Donna M Wilcock	post-doc
Gary L. Wenk	post-doc	1981-1982	Albert Einstein

Collaborators

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
Jimenez H, Carrion J, Adrien L, et al. (2023) The Impact of Muscarinic Antagonism on Psychosis-Relevant Behaviors and Striatal [C] Raclopride Binding in Tau Mouse Models of Alzheimer's Disease. Biomedicines. 11
Davidowitz EJ, Lopez P, Jimenez H, et al. (2023) Small molecule inhibitor of tau self-association in a mouse model of tauopathy: A preventive study in P301L tau JNPL3 mice. Plos One. 18: e0286523
Eun JD, Jimenez H, Adrien L, et al. (2022) Anesthesia promotes acute expression of genes related to Alzheimer's disease and latent tau aggregation in transgenic mouse models of tauopathy. Molecular Medicine (Cambridge, Mass.). 28: 83
Jimenez H, Adrien L, Wolin A, et al. (2022) The impact of pimavanserin on psychotic phenotypes and tau phosphorylation in the P301L/COMT- and rTg(P301L)4510 mouse models of Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 8: e12247
Alpaugh M, Masnata M, de Rus Jacquet A, et al. (2022) Passive immunization against phosphorylated tau improves features of Huntington's disease pathology. Molecular Therapy : the Journal of the American Society of Gene Therapy
Wesseling H, Mair W, Kumar M, et al. (2020) Tau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimer's Disease. Cell
Goodwin MS, Sinyavskaya O, Burg F, et al. (2020) Anti-tau scFvs Targeted to the Cytoplasm or Secretory Pathway Variably Modify Pathology and Neurodegenerative Phenotypes. Molecular Therapy : the Journal of the American Society of Gene Therapy
Xia Y, Prokop S, Gorion KM, et al. (2020) Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer's disease and other tauopathies. Acta Neuropathologica Communications. 8: 88
Davidowitz EJ, Krishnamurthy PK, Lopez P, et al. (2019) In Vivo Validation of a Small Molecule Inhibitor of Tau Self-Association in htau Mice. Journal of Alzheimer's Disease : Jad
Rubenstein R, Chang B, Grinkina N, et al. (2017) Tau phosphorylation induced by severe closed head traumatic brain injury is linked to the cellular prion protein. Acta Neuropathologica Communications. 5: 30

See more...